Drug Database
Back to search

Belgium· BE-AMP-SAM114606-00

Intralipid 20 %

A fettemulsionen product containing glycine max - glycine soja (ph.eur. mixture), oil - purified, registered in Belgium by Fresenius Kabi. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedIntralipid 20 %ATCB05BA02REGISTER NO.BE-AMP-SAM114606-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glycine max - glycine soja (ph.eur. mixture), oil - purifiedAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fettemulsionen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA02 (fettemulsionen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search fettemulsionen products by name

Fettemulsionen · ATC B05BA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Glycine max - Glycine soja (Ph.Eur. mixture), Oil - Purified
Manufacturer
Fresenius Kabi
Country
Belgium (BE)
ATC code
B05BA02
ATC class
Fettemulsionen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0103200
  • be_apb
    0724369

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under B05BA02

Fettemulsionen, as other registers publish it.

All fettemulsionen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b23d5938-8c85-4fe9-8981-4af597d481c2
GET /v1/drugs/b23d5938-8c85-4fe9-8981-4af597d481c2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsion for infusion",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Intralipid 20 %",
  "name_fr": "Intralipid 20 %",
  "name_nl": "Intralipid 20 %",
  "amp_code": "SAM114606-00",
  "strengths": [
    "20.0000",
    "20.0000",
    "2.2000"
  ],
  "pack_count": 1,
  "substances": [
    "Glycine max - Glycine soja (Ph.Eur. mixture), Oil - Purified",
    "Glycerol",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Fat Emulsions",
  "authorisation_numbers": [
    "BE114606"
  ]
}
API referenceMCP serverPlans

See everything about fettemulsionen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console